4//SEC Filing
CARLSON MARILYN R. 4
Accession 0001209191-20-015842
CIK 0001403708other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:14 PM ET
Size
5.8 KB
Accession
0001209191-20-015842
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
CARLSON MARILYN R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-28+200,000→ 200,000 totalExercise: $1.23Exp: 2030-02-27→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on January 1, 2020, subject to the reporting person's continued service to the issuer through each such vesting date. The other half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on the date, if any, on which the U.S. Food and Drug Administration approves the Issuer's new drug application for Gimoti, subject to the reporting person's continued service to the issuer through each such vesting date.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
Related Parties
1- filerCIK 0001592848
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:14 PM ET
- Size
- 5.8 KB